Lerryn Martin

Sector Knowledge Lawyer
Knowledge Lawyer
London

Lerryn is a senior associate in our corporate team, who is based in our London office.

Lerryn Martin photo

Related insights

Pharma M&A is back - H1 2026 Update
Blog post

Pharma M&A is back - H1 2026 Update

Having entered yet another year with renewed optimism, the first half of 2026 did not fail to deliver. Deal volume and overall value are both going strong and, if this momentum continues, 2026 is on track to be one of the best for deal activity the sector for a number of years.

The EU Commission's new draft merger guidelines - key takeaways for pharma companies

2026 sees China's biotech scene continuing its ascent – but could US developments mean clouds on the horizon?

Self-driving vehicles take to the road: UK government publishes pilot scheme guidance

View all insights